COVID–19 Vaccine Distribution and Production Act
Latest action · Oct 2, 2020 Referred to the House Committee on Financial Services.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 2, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
COVID-19 Vaccine Distribution and Production Act
This bill requires the President to, within one day, exercise certain authorities under the Defense Production Act of 1950 to obtain supplies necessary to distribute and administer COVID-19 (i.e., coronavirus disease 2019) vaccines. That act confers on the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods for the national defense.
The President must allocate these supplies based on requests from governors and the needs of the states as determined by the population of each state.
The bill's directive to use these authorities terminates when all requests from the states have been fulfilled. Supplies that have been produced but are unused at that time must be deposited into the Strategic National Stockpile.
Cosponsors 2
Members who signed on, in the order they did. All signed on Oct 2, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-DE | Lisa Blunt Rochester | Original | Oct 2, 2020 |
| D-WI | Mark Pocan | Original | Oct 2, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Financial Services Committee | Referred Oct 2, 2020 |
Actions 2
Everything that happened, newest first.
- Oct 2, 2020Introduced in House
- Oct 2, 2020Referred to the House Committee on Financial Services.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 172, October 2, 2020, page H5668.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 7018 | COVID–19 Emergency Production Act | Related bill | May 26, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of the supplies necessary for distributing and administering the COVID-19 vaccine, and for other purposes.
- Short Title(s) as Introduced
- COVID–19 Vaccine Distribution and Production Act
Subjects
Assigned by the Library of Congress. Policy area: Government Operations and Politics.
- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Government Operations and Politics
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Military procurement, research, weapons development
- Public contracts and procurement
- State and local government operations
- Strategic materials and reserves
Text 1
Each version as it was printed, newest first.
- Oct 2, 2020Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.